International Society for antiviral research

Home
ICAR2023
Detailed Schedule

Detailed program Schedule

Program Schedule (includes short oral presenters)

Click here to view Schedule-at-a-Glance.

*All times are listed in Central European Time

Monday, March 13, 2023
12:00 PM - 1:45 PM CET	Special Event: Women in Science Roundtable Chaired by Kara Carter
2:00 PM - 4:15 PM CET	Opening Session and Plenary Session Chaired by Kathie Seley-Radtke and Luis Schang Esteban Domingo, Spanish Research Council (CSIC) The Quasispecies Challenge: In Search of Antiviral Synergisms with Lethal Mutagens Laurent Fraisse, Drugs for Neglected Diseases initative (DNDi) Addressing Viral Infections in Neglected Patient Populations: The Drugs for Neglected Diseases initiative’s Efforts in HIV, HCV, COVID-19 and Pandemic Preparedness, and Dengue
4:15 PM - 4:30 PM CET	Break
4:30 PM - 5:30 PM CET	Gertrude Elion Memorial Award Lecture Chaired by Kara Carter and Kathie Seley-Radtke Fabien Zoulim, Lyon University, Hospices Civils de Lyon, INSERM Unit 1052 2023 Gertrude Elion Memorial Award Recipient Discovery Science for the Cure of Hepatitis B Virus Infection
5:30 PM - 6:30 PM CET	Opening Reception

Tuesday, March 14, 2023
8:30 AM - 9:15 AM CET	William Prusoff Memorial Award Lecture Chaired by Luis Schang and Kathie Seley-Radtke *Timothy Sheahan, Gillings School of Global Public Health, UNC at Chapel Hill 2023 William Prusoff Memorial Award Recipient* *Preparing for Tomorrow’s Pandemics, Today through the Development of Broad-spectrum Antivirals*
9:15 AM - 10:15 AM CET	SARS-CoV-2, Arboviruses, Other Biothreat Viruses, and Broad Spectrum Antivirals I Chaired by Mindy Davis and Kathie Seley-Radtke *Jinhong Chang, Baruch S. Blumberg Institute Development of an Orally Available Antiviral Drug for Yellow Fever* Marnix Van Loock, Johnson & Johnson A Pan-serotype Antiviral to Prevent and Treat Dengue: A Journey from Discovery to Clinical Development
10:15 AM - 10:30 AM CET	Break
10:30 AM - 11:00 AM CET	SARS-CoV-2, Arboviruses, Other Biothreat Viruses, and Broad Spectrum Antivirals I (continued) Chaired by Dahai Luo and María Jesús Pérez Pérez Vincent Tagliabracci, UT Southwestern Medical Center The Mechanism of RNA Capping by SARS-CoV-2
11:00 AM - 12:00 PM CET	PechaKucha Competition
12:00 PM - 1:30 PM CET	Special Event: Career Development Interactive Roundtable Chaired by Leen Delang *More information coming soon!*
2:00 PM - 2:45 PM CET	Women and Excellence in Science Award Lecture Chaired by Kathie Seley-Radtke Joanne Lemieux, University of Alberta 2023 Women in Science Award Recipient Structural Studies Facilitate Antiviral Drug Development Targeting the SARS-CoV-2 Main Protease and Variants of Concern
2:45 PM - 3:45 PM CET	Chronic, Persistent, or Latent Viruses I Chaired by Jinhong Chang and David Durantel Thomas Kledal, Synklino Fast and Efficient Elimination of Latent and Lytic CMV Infection Maura Dandri, University Medical Center Hamburg-Eppendorf (UKE) Challenges in Anti-Hepatitis D Virus Research: Insights from Preclinical and Clinical Studies
3:45 PM - 4:00 PM CET	Break
4:00 PM - 5:00 PM CET	Chronic, Persistent, or Latent Viruses I (continued) Chaired by Kara Carter and Fabien Zoulim Eric Lansdon, Gilead Sciences Structural Mechanism of Drug Resistance to L-nucleosides Conferred by the HIV-1 Reverse Transcriptase M184V Mutation Zlatko Janeba, Institute of Organic Chemistry and Biochemistry Fine-tuning Prodrugs of Acyclic Nucleoside Phosphonates
5:00 PM - 7:00 PM CET	Poster Session 1 Light food and beverages provided

Wednesday, March 15, 2023
8:15 AM - 8:30 AM CET	Tribute to Mike Bray
8:30 AM - 10:00 AM CET	Influenza, RSV, and Other Respiratory Viruses Chaired by Anne Moscona and Marco Vignuzzi Rebecca Dutch, University of Kentucky College of Medicine Human Metapneumovirus: New Insights, New Mechanisms, New Targets Sean Whelan, Washington University School of Medicine - St. Louis Inhibitors of the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Xavier Saelens, VIB-UGent Center for Medical Biotechnology Single-domain Antibodies to Control Respiratory Viruses
10:00 AM - 10:15 AM CET	Break
10:15 AM - 11:30 AM CET	Influenza, RSV, and Other Respiratory Viruses (continued) Chaired by Cybele Garcia and Brett Hurst Short presentations
11:30 AM - 12:15 PM CET	Late-breaking Oral Presentations Chaired by Robert Jordan and Angela Corona
12:15 PM - 2:15 PM CET	Poster Session 2 Lunch provided

Thursday, March 16, 2023
8:30 AM - 9:15 AM CET	Antonín Holý Memorial Award Lecture Chaired by Luis Schang and* Kathie Seley-Radtke* *Vincenzo Summa, University of Naples Federico II 2023 Antonín Holý Award Recipient* Tracking the Journey Towards the Discovery of Raltegravir and Grazoprevir: Two Intriguing Tales on Antiviral Drug Discovery
9:15 AM - 10:15 AM CET	Chronic, Persistent, or Latent Viruses II Chaired by Antoine Alam and Graciela Andrei Jocelyne Piret, Laval University Perspectives for the Management of CMV Infections in the New Era of Antiviral Agents Ben Berkhout, University of Amsterdam HIV Keeps on Surprising Us: a CRISPR-Cas Cure Adventure and a Drug-resistance Story
10:15 AM - 10:30 AM CET	Break
10:30 AM - 12:00 PM CET	Chronic, Persistent, or Latent Viruses II (continued) Chaired by Chris Meier and Jennifer Moffat Franck Gallardo, NeoVirTech SAS Combining Autofluorescent ANCHORTM Tagged Viruses with High Content Imaging for the Discovery of New Broad-spectrum Herpes Virus Inhibitors Short presentations
12:00 PM - 12:15 PM CET	ISAR Annual Business Meeting
2:00 PM - 2:45 PM CET	Diversity and Excellence in Science Award Lecture Chaired by Victor Garcia-Martinez and Luis Schang Blanton Tolbert, Case Western Reserve University 2023 Diversity Speaker Award Recipient How a Love of RNA Biophysics Led to the Discovery of a Novel Antiviral Against Enteroviruses
2:45 PM - 3:45 PM CET	SARS-CoV-2, Arboviruses, Other Biothreat Viruses, and Broad Spectrum Antivirals II Chaired by Andrea Brancale and Jessica Spengler Allison Groseth, Institute of Molecular Virology and Cell Biology (IMVZ), Friedrich-Loeffler-Institut Understanding the Arenavirus-host Cell Interface as a Guide to the Development of Novel Antiviral Approaches Robert Davey, NEIDL, Boston University Drug Repurposing at High Biocontainment: Lessons Learnt from Screening Against Ebola and SARS-CoV-2 Viruses
3:45 PM - 4:00 PM CET	Break
4:00 PM - 6:00 PM CET	SARS-CoV-2, Arboviruses, Other Biothreat Viruses, and Broad Spectrum Antivirals II (continued) Chaired by Zlatko Janeba and Christina Spiropoulou Short presentations
6:00 PM - 8:00 PM CET	Closing Event

Friday, March 17, 2023
9:00 AM - 10:30 AM CET	Acute GI Viruses Chaired by Brian Gowen and Joana Rocha-Pereira Nihal Altan-Bonnet, National Institutes of Health (NIH) Enteric Viruses Replicate in Salivary Glands and Infect Through Saliva Marcella Bassetto, Swansea University Computer-aided Approaches Towards the Development of Small-molecule Antivirals for Norovirus Infections You Li, UNC at Chapel Hill Anti-hepatovirus Activity of TENT4A/B Inhibitors
10:30 AM - 10:45 AM CET	Break
10:45 AM - 12:00 PM CET	Chronic, Persistent, or Latent Viruses III Chaired by Graciela Andrei and Jennifer Moffat Short presentations
12:00 PM - 12:30 PM CET	Shotgun Presentations and Closing Remarks Shotgun Presentations Chaired by Two Trainees TBD

About ISAR

The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.

ISAR

info@isaricar.com
1-571-349-0079